Aromatase inhibitors as a therapeutic strategy for male prolactinoma resistant to dopamine agonists: a retrospective cohort study and literature review.
D G Z GuerreroMatheo Augusto Morandi StumpfA L S MonteiroAndrea GlezerPublished in: Journal of endocrinological investigation (2023)
AI might be an option for men with resistant prolactinoma who have an increase in PRL levels on TRT. Nevertheless, prospective randomized clinical trials are needed to ensure efficacy and security for this approach.